graduate companies

149 Medical

AAVPACK

Accurvec Biotech

AChemtek

Acotrix, Inc

Advanced Diagnostic Technologies

Agilux Laboratories

Acquired by Charles River Laboratories

Alpha-Beta Technology, Inc.

Acquisition

Alpha-Beta was the second ever startup company to enter the MBI incubator. The company reached a peak headcount of 220 employees and peak market capitalization of $350 million, before being sold in 1999. Products developed by the startup are now marketed as Wellmune by Kerry, a global health and nutrition company.

Amachumu Bio

Anteros Bio

We're on a journey to help couples reclaim their intimacy by providing the first at-home genital microbiome test kit for couples that will help answers your questions about recurring UTIs, Yeast Infections, Inflammation, Discomfort and more.

Antigen Express, Inc

Acquired by Generex

Antigen Targeting Consulting

Arogy Tx

Astraeus Technologies

Atoxin Biotech LLC

Attogen, Inc

Avatar Pharmaceuticals

Acquired by Vertex Pharmaceuticals

Averica Discovery Services Inc

Acquired by NeoPharm

Beckman Coulter

Acquired by Danaher

Bio-Detail Corporation

BioChron, LLC

Biocytogen, LLC

IPO, $335M+

Bioflash Partners, LLC

Acquired by Repligen

BioFluentLabs

Bioheart

Bioinformatics.org

Biolyceum

Biomere

Acquired by JOINN Laboratories Co. Ltd.

BioPact

BioTechnic Products LTD

Biotrofix, Inc.

Blue Sky Biotech, Inc

Acquired by Curia

Boston Biokeys Corporation

Carepoint Solutions, Inc

Cell Mosaic

CellEdit, LLC

Clock Coach

Coley Pharmaceutical Group, Inc

Acquired by Pfizer

Convergent Dental

$115M+ raised, commercialized product

Convergent Dental, Inc. is a privately owned dental equipment and technology company. The Company’s flagship product, Solea®, is the only CO2 laser to be cleared by the FDA for all-tissue indications and delivers an anesthesia-free, blood-free, suture-free experience that dentists can rely on.

Creoptix

Acquired by Malvern Panalytical

Crow’s Nest Bioventures & Greater Good Imperial Brewing, Co.

Cureport

CytoVera, Inc

DermBiont

Leveraging skin microbiome therapeutics to treat, cure, and prevent skin diseases. DermBiont is advancing targeted topical therapeutics for dermatological indications. Their products in development are all first-in-class with well-defined mechanisms of action and address the root cause of skin diseases.

DNX Resource Group, Inc

DXA Resource Group, Inc.

Founded in 2002, DRG recognized the need for cost-effective and responsive DXA (Dual- Emission X-Ray Absorptiometry) clinical quality assurance, project management and data management services to support drug development.

ECI Biotech

Acquired by Alira Health

Edelweiss Immune

Novel therapeutics for autoimmune diseases. Edelweiss Immune is dedicated to developing novel therapeutics with better selectivity, safety, and efficacy for patients suffering autoimmune diseases such as multiple sclerosis, inflammatory arthritis, and psoriasis.

Eden Research

Enable Life Sciences

Enable Life Sciences facilitates Innovation in the life sciences. We bring the innovative plans and aspirations of our clients to reality through Planning, Creation and Execution. We enable success through customized Innovation Management and R&D Project Management services, including collaborations at a global scale. We serve a broad array of clients including those in medical devices, pharmaceuticals, biotechnology, diagnostics, mHealth and healthcare delivery industries.

Enrich Therapeutics

Entegrion, Inc

EpigenDx

Fluidform

GAMA Therapeutics

Gemini Medical, Inc.

Genome Quest, Inc

Gliese623B

Gliese623B provides consultant services in the areas of pre-clinical medical device validation support for 510K premarket notification submissions with the FDA. We also provide drug discovery solutions and manufacture support, study design & protocol development, pre-clinical method validation, R&D outsourcing, SOP authorship, risk assessments, and gap analysis. For developed programs we provide clinical trial and support through a network of medical teaching institutions and hospitals.

GlycoSolutions Corporation

GQ Life Sciences

Acquired by Aptean

Grove Instruments, Inc

HDL Therapeutics, Inc.

HelixBind

Histologistics

HSRL, Inc.

Acquired by StageBio

HSRL started their Massachusetts presence at MBI in 2016 and grew their sales to the point where they secured an investment from Ampersand Capital, acquired a few companies and rebranded as StageBio. StageBio is a leading provider of GLP-compliant necropsy, histology, pathology, and specimen archiving services for the biopharmaceutical, medical device, academic, and contract research industries.

Hypromatrix, Inc

Incite Advisors, Inc

Innolign Biomedical

Intelligent Bio-Systems

Acquired by Qiagen

Invetx

IPO, $80M+

iOmics Corporation

iVexSol

Series A

iVexSol, whose mission is to improve patients' lives by developing transformative vector production technologies, graduated from MBI in 2022 with 20+ employees and has raised $40M to date.

Janus Biotherapeutics

JURA Bio, Inc.

At JURA Bio, we combine the next generation machine inference with the world’s largest high-quality biological datasets and autonomously optimized iterative design. The result? Drug discovery and development for genomic medicine as we’d only dreamed possible.

JuvoBio Pharmaceuticals

KBioBox, LLC

KeraCure, Inc

Leveragen

Leveragen is a Massachusetts-based biotech company specializing in genetic engineering. We develop comprehensive solutions for genetic modeling, creating designer mutations to study gene function and disease mechanisms.

Loop CO2

Loop CO2, inc. is a green chemistry research and development startup. The company is one of the grant awardees by Department of Energy. We are specialized in developing a new class of polyester materials in the form of pellets for manufacturing consumer products from a CO2-derived monomer feedstock.

Matrigen Life Technologies

MedTherapy Biotech

MICROBAC

MicroECM

MSM Protein Technologies

MyoSyntax

NanoBio Systems

Nemucore Medical Innovations, Inc

Niagara Biosciences

Nirogyone Therapeutics

NOMIR Medical Technologies

Nyla Laboratories

Acquired

Olaf Pharmaceuticals

OptoGlo

OptoGlo has invented an advanced material that is radically changing the functionality of signs. Instantly display messaging and advertising without wires – day or night.

Or-Genix Therapeutics

Ostroff Consulting

Otomagnetics

PackGene Biotech, Inc.

Pananosis

A platform blood-based diagnostic test powered by computationally analyzing immune footprint patterns

Performance Indicator

Pharma Models, LLC

ProFoldin

Propel Biosciences

Provia Labs

Ravissanics, Inc

Robyn Robotics

RXI Pharmaceuticals

Seamless Therapeutics

Seamless Therapeutics is changing the paradigm of gene editing through a pioneering approach to restore health in patients with severe conditions in a safe and precise manner.

Solarea Bio

Solarea Bio is a biotech company building solutions for health disorders using bacteria and fungi native to healthy foods to create powerful synergistic, anti-inflammatory microbial assemblages.

Spring Bank Pharmaceuticals

Acquired by F-Star Therapeutics, Inc.

Stability Health

Stryker Orthobiologics

Suco, LLC

Sufacine Development Company

T2 Biosystems

IPO

Targeted Biosciences, Inc.

Targeted Pharmaceuticals

Acquired by Tetra Bio-Pharma

Tarpon Biosystems, Inc

Tech Acquisition by Pall

Technical Innovation Center

Time Bioscience

TransCode Therapeutics

IPO, $7M

TransCytos

uBriGene

uBriGene Bioscience Inc. is a leading contract development and manufacturing organization (CDMO), specializing in the development and application of cell and gene therapy technologies.

VecX Biomedicines

VecX Biomedicines is an AI-driven biotech company existing at the intersection of computational protein design, bioengineering, synthetic biology, and medicine and pioneering gene therapy to create breakthrough medicines.

Verax Biomedical

Verne Bioanalytics

ViaCell, Inc

IPO and Acquired by Perkin Elmer

Vivo Path LLC

Acquired by Charles River Laboratories

Weddell Technologies

Welgen, Inc.

WesaGen, Inc

WntRx Pharmaceuticals

Woodland Biosciences

Acquired by Ichor Life Sciences

X Therapeutics

Next generation of medicines to treat infectious disease

Yurogen Biosystems, LLC

Acquired by ABClonal Science Inc.